Newco Dezima in-licenses Mitsubishi dyslipidemia compound

Mitsubishi Tanabe Pharma Corp. (Tokyo:4508; Osaka:4508) granted newco Dezima Pharma B.V. (Naarden, the Netherlands) exclusive, worldwide rights, excluding certain Asian territories, to dyslipidemia co...